|
ZNF274 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.40779999564012E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.15019999996835E-06 |
| Normal-vs-Stage2 |
2.35739999999707E-05 |
| Normal-vs-Stage3 |
5.67819999908181E-08 |
| Normal-vs-Stage4 |
9.52079999999578E-05 |
| Stage1-vs-Stage2 |
1.142960E-01 |
| Stage1-vs-Stage3 |
3.100000E-02 |
| Stage1-vs-Stage4 |
4.208000E-01 |
| Stage2-vs-Stage3 |
9.873600E-01 |
| Stage2-vs-Stage4 |
5.487400E-01 |
| Stage3-vs-Stage4 |
4.595000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.93099999995705E-07 |
| Normal-vs-AfricanAmerican |
1.659130E-03 |
| Normal-vs-Asian |
9.915400E-03 |
| Caucasian-vs-AfricanAmerican |
8.128000E-01 |
| Caucasian-vs-Asian |
1.534420E-01 |
| AfricanAmerican-vs-Asian |
2.516400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95064999999328E-05 |
| Normal-vs-Female |
7.74230000111231E-08 |
| Male-vs-Female |
4.477600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.14160000000718E-05 |
| Normal-vs-Age(41-60Yrs) |
3.72070000032032E-07 |
| Normal-vs-Age(61-80Yrs) |
2.9516999955348E-08 |
| Normal-vs-Age(81-100Yrs) |
2.213400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.139620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.422220E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.432200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.922800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.492000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.619000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.015100E-03 |
| Classical-VS-Follicular |
1.75300999999406E-05 |
| Classical-VS-Other |
6.750600E-01 |
| Classical-VS-Normal |
5.98979999999472E-05 |
| Tall-VS-Follicular |
4.490000E-01 |
| Tall-VS-Other |
3.079400E-01 |
| Tall-VS-Normal |
5.38260000015889E-07 |
| Follicular-VS-Other |
2.831800E-01 |
| Follicular-VS-Normal |
5.08149999856045E-09 |
| Other-VS-Normal |
7.130100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.60689999773834E-08 |
| Normal-vs-N1 |
6.421200E-04 |
| N0-vs-N1 |
3.221200E-01 |
|
|
